Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Push Health vs Ryze Rx

Push Health
Graded #419

Lower grade

vs+2
Ryze Rx
Graded #376

Higher grade

The verdict

Ryze Rx takes it — 58.2/100 to 56.2/100, but only just.

Ryze Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Ryze Rx is a prescription telehealth platform for weight loss, TRT and peptide therapy, prescribing through board-certified physicians and shipping from US-licensed compounding pharmacies. Push Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRyze Rx +9
35
44
Dose & formulationPush Health +1
65
64
Clinical oversightRyze Rx +4
71
75
Labs & monitoringEven
52
52
FulfillmentRyze Rx +2
67
69
Contract termsPush Health +14
55
41
Push Health · left barRyze Rx · right bar

The numbers

MetricPush HealthRyze Rx
WeighScore56.2/10058.2/100
GradeCC
Scorecard rank#419#376
Semaglutide$950/mo (brand-name)$199/mo (starting dose, 3 month plan, compounded)
TirzepatideNot disclosed$199/mo (starting dose, 3 month plan, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Push Health

Graded #419 · C

Strengths

  • Brand-name-only GLP-1 distribution (Ozempic, Zepbound, Mounjaro)
  • 55,000+ pharmacy network per competitor sources
  • LegitScript certified per competitor sources
  • Listed in both competitor directories

Where it loses points

  • Brand-name-only — no compounded option
  • Stub entry — exact pricing, insurance coordination, and clinician workflow need YMYL verification
  • Confidence LOW until verified
Ryze Rx

Graded #376 · C

Strengths

  • Compounded semaglutide and tirzepatide both $199/mo, with $499/$799 three-month bundles
  • Physician consultation, ongoing clinical support and discreet shipping included with each prescription
  • Broad catalog beyond GLP-1: TRT plus peptides (BPC-157, sermorelin, NAD+, retatrutide and more)
  • Free shipping, 24hr prescription turnaround, FSA/HSA eligible; care advertised in all 50 states

Where it loses points

  • Terms, Privacy Policy and HIPAA notice are dead links - no legal entity, refund policy or governing law disclosed
  • Pharmacy partners not named - only 'US-licensed compounding pharmacies'
  • Homepage advertises GLP-1s 'from $149/mo' but the catalog lists $199/mo
  • On-site '4.9/5, 2,400+ reviews' is self-reported, not an independently verified rating

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard